Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “UROTHELIAL CARCINOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01222676
What this trial is testing

Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder

Who this might be right for
Bladder Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 45
Testing effectiveness (Phase 2)Study completedNCT00080795
What this trial is testing

Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
M.D. Anderson Cancer Center 65
Testing effectiveness (Phase 2)UnknownNCT03219775
What this trial is testing

Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma

Who this might be right for
Transitional Cell CarcinomaAdvanced CancerMetastatic Cancer
AIO-Studien-gGmbH 169
Testing effectiveness (Phase 2)Ended earlyNCT04936230
What this trial is testing

Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer

Who this might be right for
Metastatic Urothelial CarcinomaPlatinum-Resistant Urothelial CarcinomaStage IV Bladder Cancer AJCC v8
National Cancer Institute (NCI) 1
Not applicableStudy completedNCT05742867
What this trial is testing

Evaluate Treatment Preferences for Japanese Participants With Muscle-invasive Urothelial Carcinoma of the Bladder

Who this might be right for
Urinary Bladder Neoplasms
Bristol-Myers Squibb 115
Large-scale testing (Phase 3)Not Yet RecruitingNCT07526792
What this trial is testing

SYS6002 vs Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
CSPC Megalith Biopharmaceutical Co.,Ltd. 406
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808216
What this trial is testing

Toripalimab Combined With Intravesical Gemcitabine as Adjuvant Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer After TURBT

Who this might be right for
Non Muscle Invasive Bladder Cancer
Tianjin First Central Hospital 54
Testing effectiveness (Phase 2)Study completedNCT00009867
What this trial is testing

Arsenic Trioxide in Treating Patients With Urothelial Cancer

Who this might be right for
Recurrent Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Urethral CancerTransitional Cell Carcinoma of the Bladder+1 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT03689192
What this trial is testing

Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors

Who this might be right for
Non Small Cell Lung CancerUrothelial CarcinomaMalignant Melanoma+5 more
Herlev Hospital 13
Not applicableWithdrawnNCT03238664
What this trial is testing

Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder Tumors

Who this might be right for
Infiltrating Bladder Urothelial CarcinomaStage II Bladder Urothelial CarcinomaTransitional Cell Carcinoma
University of Southern California
Testing effectiveness (Phase 2)Study completedNCT01328574
What this trial is testing

TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaUreteral NeoplasmsUreter Cancer+2 more
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793578
What this trial is testing

Immunotherapy Plus Capivasertib for Metastatic Bladder Cancer

Who this might be right for
Advanced Urothelial Carcinoma
VA Office of Research and Development 32
Testing effectiveness (Phase 2)Looking for participantsNCT06822010
What this trial is testing

SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma

Who this might be right for
Urinary Bladder CancerUpper Tract Urothelial CancerUrothelial Cancer
Rutgers, The State University of New Jersey 28
Testing effectiveness (Phase 2)Study completedNCT04701918
What this trial is testing

Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma

Who this might be right for
Metastatic Urothelial CarcinomaBladder Cancer
Massachusetts General Hospital 9
Testing effectiveness (Phase 2)Study completedNCT00790426
What this trial is testing

Phase II Study of TKI258 in Advanced Urothelial Carcinoma

Who this might be right for
Urothelial Cancer
Novartis Pharmaceuticals 44
Not applicableStudy completedNCT04822350
What this trial is testing

A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA

Who this might be right for
Urothelial Carcinoma
Pfizer 596
Testing effectiveness (Phase 2)Study completedNCT00154687
What this trial is testing

Weekly TP-HDFL in the Treatment of Advanced TCC

Who this might be right for
Transitional Cell Carcinoma
National Taiwan University Hospital 40
Not applicableLooking for participantsNCT05595408
What this trial is testing

Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma

Who this might be right for
Muscle Invasive Upper Tract Urothelial Carcinoma
RenJi Hospital 84
Testing effectiveness (Phase 2)UnknownNCT02535650
What this trial is testing

Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Samsung Medical Center 19
Not applicableLooking for participantsNCT05646485
What this trial is testing

Bladder Cancer Screening Trial

Who this might be right for
Bladder CancerUrothelial CarcinomaHematuria+1 more
University of Texas Southwestern Medical Center 1,000
Next Page